Perifosine is company’s new oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer. Reportedly, the trial
Aurobindo Pharma said that Venlafaxine Hydrochloride tablets are the generic equivalent of Wythe Pharmaceutical’s Effexor tablets. Effexor XR (venlafaxine hydrochloride) extended-release capsules are prescription antidepressant and indicated for
Reportedly, the original 2007 Agreement had provided MaxCyte’s cell loading system for use in Medinet’s Dendritic Cell (DC) Vaccine Therapy in Japan. Medinet is currently marketing its DC
In the trial, Fidaxomicin met the primary endpoint of non-inferiority in clinical cure compared to Vancocin. Fidaxomicin also had lower recurrence rates compared to Vancocin and significantly higher
Levadex is an orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine. The trial was initiated in support of a
The new representation centre is expected to intensify Gerresheimer’s business in pharmaceutical primary packaging and drug-delivery systems. Gerresheimer said that the regional representation is expected to contribute to
Emerging World Pharma focuses its investments on generic pharmaceutical companies that have contracts with three major buyer groups; church, government and wholesalers. The investment would entitle Emerging World
The E-Tryton 150 study enrolled 151 patients and E-Tryton Benelux enrolled 155. The primary endpoint of the studies is the overall rate of major adverse cardiac events (MACE)
Sun Pharmaceutical said that these generic Bupropion Hydrochloride extended release tablets are equivalent to GlaxoSmithKline’s Wellbutrin SR extended release tablets and includes three strengths: 100mg, 150mg and 200mg.
Vivalis said that the milestone recognises the completion of the characterisation program of the EB66 cell line according to the current regulatory requirements. The worldwide collaboration and license
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.